Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG)

CAPS Rating: 2 out of 5

The Company is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs.

Recs

0
Player Avatar pchop123 (76.58) Submitted: 7/10/2012 10:18:28 AM : Underperform Start Price: $11.18 ROSG Score: +11.58

NO major drver at this point that has efficacy

Featured Broker Partners


Advertisement